EUVIMEDEUVIMED entdecken
Crossref

Cefazolin vs Antistaphylococcal Penicillins for Methicillin-Susceptible Staphylococcus aureus Bacteremia—Convergence of Observational and Randomized Evidence

Michihiko Goto

JAMA Network Open · 12.11.2026 · 9 (11) · e2643842

DOI: 10.1001/jamanetworkopen.2026.43842 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 12.11.2026. Verfasst von Michihiko Goto. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City. Die Arbeit nennt 7 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Division of Infectious Diseases, Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City.
  • Center for Access & Delivery Research and Evaluation (CADRE), Iowa City VA Health Care System, Iowa City, Iowa.

Zitieren

APA

Goto, M. (2026). Cefazolin vs Antistaphylococcal Penicillins for Methicillin-Susceptible Staphylococcus aureus Bacteremia—Convergence of Observational and Randomized Evidence. JAMA Network Open, 9(11), e2643842. https://doi.org/10.1001/jamanetworkopen.2026.43842

Vancouver

Goto M. Cefazolin vs Antistaphylococcal Penicillins for Methicillin-Susceptible Staphylococcus aureus Bacteremia—Convergence of Observational and Randomized Evidence. JAMA Network Open. 2026;9(11):e2643842. doi:10.1001/jamanetworkopen.2026.43842

BibTeX
@article{Goto2026,
  author = {Goto, Michihiko},
  title = {Cefazolin vs Antistaphylococcal Penicillins for Methicillin-Susceptible Staphylococcus aureus Bacteremia—Convergence of Observational and Randomized Evidence},
  journal = {JAMA Network Open},
  year = {2026},
  volume = {9},
  number = {11},
  pages = {e2643842},
  doi = {10.1001/jamanetworkopen.2026.43842}
}
Kostenlos starten →